Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer (Q43784117)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2001
edit
Language Label Description Also known as
English
Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer
scientific article published in August 2001

    Statements

    Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer (English)
    1 August 2001
    4 Suppl 15
    67-70

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit